Buthalital
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C11H15N2NaO2S |
Molar mass | 262.30 g·mol−1 |
3D model (JSmol) | |
| |
|
Buthalital sodium (INN; Bayinal, Baytinal, Thialbutal, Transithal, Ulbreval), or buthalitone sodium (BAN), is a barbiturate derivative which was under development as a short-acting anesthetic.[1][2] However, development was discontinued, perhaps due to its extremely rapid elimination rate,[3] and buthalital sodium was never marketed.[1]
See also
[edit]References
[edit]- ^ a b Macdonald F (1997). Dictionary of Pharmacological Agents. CRC Press. p. 338. ISBN 978-0-412-46630-4. Retrieved 19 May 2012.
- ^ Martin JR, Godel T, Hunkeler W, Jenck F, Moreau JL, Sleight AJ, Widmer U (2000). "Psychopharmacological Agents". Kirk-Othmer Encyclopedia of Chemical Technology. doi:10.1002/0471238961.1619250313011820.a01. ISBN 0471238961.
- ^ Wollweber H (2000). "Anesthetics, General". Ullmann's Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH. doi:10.1002/14356007.a02_289. ISBN 978-3527306732.